Literature DB >> 3311497

MHC antigen expression in sequential biopsies from cardiac transplant patients--correlation with rejection.

A Suitters1, M Rose, A Higgins, M H Yacoub.   

Abstract

Class I induction on the myocardium of transplanted heart was investigated with regard to its temporal relationship to rejection episodes, how it is affected by anti-rejection therapy and whether it is dependent upon the presence of a T cell infiltrate in the biopsy. Sequential cardiac biopsies (total 114) from 11 patients from the time of transplant to 1 year after transplant were studied using immunocytochemical techniques. The effect of different immunosuppressive regimens on MHC antigen expression was also studied. All the biopsies diagnosed as showing rejection for the first time showed induction of Class 1 on the myocardium with 79% during subsequent rejection episodes. Class I induction was associated with a leucocyte infiltrate, not always containing T cells, and disappeared in 47% of biopsies taken 3-4 weeks after treatment with steroids and/or ATG. Increased expression of Class II, in particular DQ antigens on interstitial structures, paralleled Class 1 induction. MHC antigen expression returned to normal in 8/9 patients, at 1 year after transplant. Different immunosuppressive regimens affected the number of biopsies showing Class 1 induction on the myocardium. Our results suggest that in clinical heart transplantation class I induction is related to the rejection process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311497      PMCID: PMC1542371     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  A study of HL-A antigens in human organs.

Authors:  M Berah; J Hors; J Dausset
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

3.  Expression of Ia-like antigens in normal human nonlymphoid tissues.

Authors:  P G Natali; C De Martino; V Quaranta; M R Nicotra; F Frezza; M A Pellegrino; S Ferrone
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

4.  Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells.

Authors:  M Fellous; M Kamoun; I Gresser; R Bono
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

5.  Specific destruction of human endothelial cell monolayers by anti-DRw antisera.

Authors:  H Hirschberg; T Moen; E Throsby
Journal:  Transplantation       Date:  1979-08       Impact factor: 4.939

6.  Sequential analysis of HLA-class II antigen expression in human renal allografts. Induction of tubular class II antigens and correlation with clinical parameters.

Authors:  S V Fuggle; D L McWhinnie; J R Chapman; H M Taylor; P J Morris
Journal:  Transplantation       Date:  1986-08       Impact factor: 4.939

7.  Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice.

Authors:  N Green; H Hiai; J H Elder; R S Schwartz; R H Khiroya; C Y Thomas; P N Tsichlis; J M Coffin
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

8.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

9.  Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat.

Authors:  R Dalchau; J Kirkley; J W Fabre
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

10.  Immunological analysis of the skin in graft versus host disease.

Authors:  I A Lampert; G Janossy; A J Suitters; M Bofill; S Palmer; E Gordon-Smith; H G Prentice; J A Thomas
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

View more
  7 in total

1.  HLA antigens in idiopathic dilated cardiomyopathy.

Authors:  C J Limas; C Limas
Journal:  Br Heart J       Date:  1989-11

2.  Establishment of a human fetal cardiac myocyte cell line.

Authors:  Y C Wang; N Neckelmann; A Mayne; A Herskowitz; A Srinivasan; K W Sell; A Ahmed-Ansari
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

Review 3.  Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen.

Authors:  Michelle J Hickey; Nicole M Valenzuela; Elaine F Reed
Journal:  Front Immunol       Date:  2016-02-04       Impact factor: 7.561

Review 4.  The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice.

Authors:  Amy Rachael Cross; Denis Glotz; Nuala Mooney
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

5.  Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation.

Authors:  Osama Omrani; Moheeb Alawwami; Jehad Buraiki; Nedim Selimovic
Journal:  Ann Saudi Med       Date:  2018 Mar-Apr       Impact factor: 1.526

Review 6.  Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.

Authors:  Giuseppe Milone; Claudia Bellofiore; Salvatore Leotta; Giulio Antonio Milone; Alessandra Cupri; Andrea Duminuco; Bruno Garibaldi; Giuseppe Palumbo
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

7.  Inflammation Determines the Capacity of Allogenic Endothelial Cells to Regulate Human Treg Expansion.

Authors:  Amy Rachael Cross; Julien Lion; Karine Poussin; Denis Glotz; Nuala Mooney
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.